With Leqembi approval in Alzheimer’s disease, Eisai and Biogen plot ‘meticulous’ launch fkansteiner Fri, 01/06/2023 – 12:44 More: With Leqembi approval in Alzheimer's disease, Eisai and Biogen plot 'meticulous' launch Source: fierce
read moreJ&J’s consumer health unit Kenvue prepares to leave the nest with IPO filing zbecker Fri, 01/06/2023 – 11:12 More: J&J's consumer health unit Kenvue prepares to leave the nest with IPO filing Source: fierce
read moreFierce Pharma Asia—Eisai’s Alzheimer’s trial deaths; Moderna’s first M&A deal; GSK, WuXi’s bispecific pact aliu Fri, 01/06/2023 – 10:36 More: Fierce Pharma Asia—Eisai’s Alzheimer’s trial deaths; Moderna’s first M&A deal; GSK, WuXi's bispecific pact Source: fierce
read morePfizer picks up steam in its pursuit of Merck’s next-gen pneumococcal vaccine kdunleavy Fri, 01/06/2023 – 09:49 More: Pfizer picks up steam in its pursuit of Merck's next-gen pneumococcal vaccine Source: fierce
read moreBluebird scores $95M nest egg after selling second FDA priority review voucher to BMS fkansteiner Fri, 01/06/2023 – 08:42 More: Bluebird scores M nest egg after selling second FDA priority review voucher to BMS Source: fierce
read moreStudy will evaluate the intravenous administration of company’s multi-armed immunotherapy More: Transgene receives approval to begin oncolytic virus trial Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals